Spatial risk of Haemaphysalis longicornis borne Dabieshan tick virus (DBTV) in China
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Xiaohu Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Livestock Infectious Diseases, Ministry of Education, Shenyang Agricultural University, Shenyang, Liaoning, People's Republic of Ch…. Hauptthemen laut MEDLINE: Ticks, Tick-Borne Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Partnership Program, Ministry of Science and Technology of China, National Key Research and Development Project, NSFC International (Regional) Cooperation and Exchange Program.
Abstract (Originalsprache)
The uncertainty and unknowability of emerging infectious diseases have caused many major public health and security incidents in recent years. As a new tick‐borne disease, Dabieshan tick virus (DBTV) necessitate systematic epidemiological and spatial distribution analysis. In this study, tick samples from Liaoning Province were collected and used to evaluate distribution of DBTV in ticks. Outbreak points of DBTV and the records of the vector Haemaphysalis longicornis in China were collected and used to establish a prediction model using niche model combined with environmental factors. We found that H. longicornis and DBTV were widely distributed in Liaoning Province. The risk analysis results showed that the DBTV in the eastern provinces of China has a high risk, and the risk is greatly influenced by elevation, land cover, and meteorological factors. The risk geographical area predicted by the model is significantly larger than the detected positive areas, indicating that the etiological survey is seriously insufficient. This study provided molecular and important epidemiological evidence for etiological ecology of DBTV. The predicted high‐risk areas indicated the insufficient monitoring and risk evaluation and the necessity of future monitoring and control work.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Livestock Infectious Diseases, Ministry of Education, Shenyang Agricultural University, Shenyang, Liaoning, People's Republic of China.
- Department of Epidemiology, School of Public Health, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
- Department of Vascular Surgery, The First Affiliated Hospital of the Navy Medical University, Shanghai, People's Republic of China.
- Animal Disease Prevention and Control Center in Qinghai Province, Xining, People's Republic of China.
- Innovative Institute of Zoonoses, Inner Mongolia Minzu University, Tongliao, People's Republic of China.
ORCID-Profile: Zeliang Chen
Förderung
- Science and Technology Partnership Program, Ministry of Science and Technology of China
- National Key Research and Development Project
- NSFC International (Regional) Cooperation and Exchange Program
- State Key Program of National Natural Science of China
- Key Program of Inner Mongolia
Zitieren
APA
Han, X., Gao, S., Xin, Q., Yang, M., Bi, Y., Jiang, F., Zeng, Z., Kan, W., Wang, T., Chen, Q., & Chen, Z. (2024). Spatial risk of Haemaphysalis longicornis borne Dabieshan tick virus (DBTV) in China. Journal of Medical Virology. https://doi.org/10.1002/jmv.29373
Vancouver
Han X, Gao S, Xin Q, Yang M, Bi Y, Jiang F, et al. Spatial risk of Haemaphysalis longicornis borne Dabieshan tick virus (DBTV) in China. Journal of Medical Virology. 2024. doi:10.1002/jmv.29373
BibTeX
@article{Han2024,
author = {Han, Xiaohu and Gao, Shan and Xin, Qing and Yang, Mingwei and Bi, Yudan and Jiang, Feng and Zeng, Zan and Kan, Wei and Wang, Tongyao and Chen, Qijun and Chen, Zeliang},
title = {Spatial risk of Haemaphysalis longicornis borne Dabieshan tick virus (DBTV) in China},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29373}
}
EUVIMED